Skip to content
Abierto

Combined synopsis and solicitation

Combines Synopsis Solicitation- NULISAseq Inflamma

75N98026Q01133

National Institutes of Health, National Institutes of Health Olao. Testing Laboratories and Services.

Response deadline

September 11, 2026 at 12:00 PM EDT

Closed 5 days ago. Posted September 2, 2026. Scheduled to archive September 26, 2026.

Description

As published on SAM.gov.

This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice.

This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. (ii) The solicitation number is 75N98026Q01133 and the solicitation is issued as a Notice of Intent (NOI) of a non-competitive (notice of intent) combined synopsis solicitation to award a contract or purchase order without providing for full or open competition (including brand-name).

This acquisition is conducted under the authority of the FAR Part 12.603¿ Streamlined solicitation for commercial products or commercial services, and is not expected to exceed the simplified acquisition threshold, and the authority of 41 U.S.C. 1901 and the statutory authority of FAR 6.302-3(a)(2)(ii).

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. September 2, 2026

    Combined synopsis and solicitation

    Due September 11, 2026 at 12:00 PM EDT. SAM.gov, notice 3cd913cab48f44478fb4ad9627fd1dd5

Points of contact